Fengjiao Zhao

Camrelizumab plus gemcitabine and oxaliplatin (GEMOX) in patients with advanced biliary tract cancer: a single-arm, open-label, phase II trial

Xiaofeng Chen, Xiaofeng Wu, Hao Wu et al. · Journal for ImmunoTherapy of Cancer · 2020 · 160 citations · Full text

Medicine, Oncology, Pharmacology +17

Genomic alterations in biliary tract cancer predict prognosis and immunotherapy outcomes

Xiaofeng Chen, Deqiang Wang, Jing Liu et al. · Journal for ImmunoTherapy of Cancer · 2021 · 65 citations · Full text

Medicine, Immunology, Oncology +17

A Single-Arm, Phase II Study of Apatinib in Refractory Metastatic Colorectal Cancer

Xiaofeng Chen, Tianzhu Qiu, Yingwei Zhu et al. · The Oncologist · 2019 · 60 citations · Full text

Medicine, Oncology, Pharmacology +17

Safety and Efficacy of Sintilimab and Anlotinib as First Line Treatment for Advanced Hepatocellular Carcinoma (KEEP-G04): A Single-Arm Phase 2 Study

Xiaofeng Chen, Wei Li, Xiaofeng Wu et al. · Frontiers in Oncology · 2022 · 47 citations · Full text

Pharmacy, Oncology, Pharmacotherapy +17

Improving therapeutic effects of exosomes encapsulated gelatin methacryloyl/hyaluronic acid blended and oxygen releasing injectable hydrogel by cardiomyocytes induction and vascularization in rat myocardial infarction model

Dan Wang, Hong Zhang, Yu Chen et al. · International Journal of Biological Macromolecules · 2024 · 19 citations

Engineering, Bioengineering, Biomedical Engineering +17